Home » Topics » BioWorld Science

BioWorld Science
RSS

Inhibiting N-glycase-1 increases the efficacy of chemotherapy in melanoma

Nov. 9, 2018

Chemokine receptor 8 identified as a marker of ANCA-negative ANCA-associated vasculitis

Nov. 9, 2018

European Commission approves expanded label for Trelegy Ellipta in COPD

Nov. 9, 2018

Cue Biopharma and LG Chem collaborate to develop Immuno-STAT biologics for cancer

Nov. 9, 2018

Innovent presents data on sintilimab in first-line squamous NSCLC

Nov. 9, 2018

Palatin reports first-in-human data on subcutaneous dosing with MC1 receptor agonist peptide PL-8177

Nov. 9, 2018

EA Pharma signs joint research agreement to advance E-6011 for Crohn's disease

Nov. 9, 2018

Gene therapy based on newly discovered EBP50 mutation improves neuropathy

Nov. 9, 2018

Tempest Therapeutics discloses prostanoid EP4 receptor antagonists

Nov. 9, 2018

Neurotensin type 1 receptor pepducin PP-001 shows analgesic activity in vivo

Nov. 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...